glutathione cancer risk

glutathione cancer risk and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione Depletion and Stalwart Anticancer

Name: glutathione cancer risk and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione Depletion and Stalwart Anticancer
Brand: iglepidom.org
SKU: 25107593035
Price: 28.40 USD
Availability: InStock
Rating: 4.807300000000001 (28 reviews)

Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega glutathione supplement cancer risk system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis Glutamine Supplementation as an Anticancer Glutathione mediated nanomedicines for cancer diagnosis and therapy ScienceDirect Glutathione prevents high glucose induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS TGF SMAD pathway Cell Death & Disease

SKU: 25107593035 · From iglepidom.org

4.8

USD28.40 USD75.40

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

The primary antibodies utilized in this study included IL-1 (1:50 dilution, 52012, Santa Cruz Biotechnology, America), TNF- (1:50 dilution, 346654, ZEN-BIOSCIENCE, China), CD44 (1:100 dilution, 14044182, eBioscience, America), ALP (1:50 dilution, 381009, ZEN-BIOSCIENCE, China), and BMP2/4 (1:50 dilution, 137087, Santa Cruz Biotechnology, America)